Keyphrases
Mastectomy
100%
Implant Reconstruction
80%
Breast Malignancy
80%
Multimodal Imaging
80%
Response to Neoadjuvant Chemotherapy
80%
HER2-positive Breast Cancer
80%
Autologous Reconstruction
80%
Cavum Septi Pellucidi
80%
Imaging Review
80%
Magnetic Resonance Findings
80%
Septo-optic Dysplasia
80%
Pediatric Kidney Transplantation
80%
Early Discontinuation
80%
Diagnostic Challenge
80%
Metabolic Syndrome
80%
Fetal Ultrasound
80%
Ultrasonic Resonance
80%
Transplantation
80%
Renal Transplant Recipients
80%
Pediatric RT
60%
Pathologic Analysis
40%
Neoadjuvant Therapy
40%
Mammography
40%
Radiologists
40%
Breast Cancer
40%
Image Features
37%
Fetal Magnetic Resonance Imaging
35%
Prenatal Imaging
26%
Magnetic Resonance Imaging
26%
Frontal Horn
26%
Lifetime Risk
20%
Surgical Planning
20%
Trastuzumab
20%
Axillary Lymph Node Dissection
20%
Malignancy
20%
Re-excision
20%
Breast Cancer Risk
20%
MRI Findings
20%
Rare Breast Cancer
20%
Breast
20%
ERBB2-positive Breast Cancer
20%
Regional Disease
20%
Human Epidermal Growth Factor Receptor 2 (HER2)
20%
Surgeons
20%
Imaging Modalities
20%
Taxanes
20%
Regional Response
20%
Best Predictor
20%
Local-regional Control
20%
Breast Reconstruction
20%
Medicine and Dentistry
Mastectomy
100%
Breast Cancer
100%
Magnetic Resonance Imaging
100%
Multimodality Imaging
80%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
80%
Cancer
80%
Septo-Optic Dysplasia
80%
Neoadjuvant Chemotherapy
80%
Diagnosis
80%
Fetus Echography
80%
Mammography
40%
Malignant Neoplasm
40%
Neoplasm
40%
Neoadjuvant Therapy
40%
Diseases
40%
Horn
30%
Monoclonal Antibody Therapy
20%
Cosmesis
20%
Magnetic Resonance Imaging of Breast
20%
Gamma Urogastrone
20%
Epidermal Growth Factor Receptor 2
20%
Lifespan
20%
Axillary Lymph Node
20%
Breast-Conservation Therapy
20%
Recurrent Disease
20%
Anthracycline
20%
Retroperitoneal Lymph Node Dissection
20%
Patient Preference
20%
Surgeon
20%
Treatment Response
20%
Sentinel Lymph Node Biopsy
20%
Metastatic Carcinoma
20%
Morphologic Abnormality
20%
Surgical Planning
20%
Monoclonal Antibody
20%
Trastuzumab
20%
Pertuzumab
20%
Adjuvant Therapy
20%
Chemotherapy
20%
Optic Nerve Hypoplasia
10%
Hypopituitarism
10%
Central Nervous System
10%
Ventricle of Heart
10%
